中文
| Catalogue |
|
|
| Recommend Products |
Carterra, Inc.
United States, Manufacturer, Hits: 1282, Updated:8/15/2019
825 N. 300 W., Suite C309 Salt Lake City, UT 84103 |
Company Profile
-
Carterra? is the leading provider of high throughput technologies designed to accelerate and improve the discovery of novel therapeutic candidates. Carterra’s LSA? instrument, software, and consumables for monoclonal antibody (mAb) characterization deliver up to 100 times the throughput of existing platforms in 10% of the time while using only 1% of the sample required by other systems. The LSA combines patented microfluidics technology with real-time high throughput Surface Plasmon Resonance (HT-SPR) and industry-leading data analysis and visualization software to revolutionize mAb screening. Carterra, Inc. is based in Salt Lake City Utah, and has Customer Experience Centers in Dublin, California, Newtown, Pennsylvania, and Munich, Germany. For additional information, please visit www.carterra-bio.com.
Company News
- Carterra Announces its 2025 Symposia Series on Speeding Drug Discovery with AI/ML and Other New Te... 4/25/2025
- Carterra Announced That It has Sold and Shipped Its First Carterra Ultra™ Biosensor Platform 1/8/2025
- Carterra Expands Best-in-class Franchise with the Launch of the LSAXT High-throughput SPR Biosenso... 3/15/2023
- Carterra Expands Best-in-class Franchise with the Launch of the LSAXT High-throughput SPR Bio... 3/1/2023
- University of Manchester Adds Carterra’s LSA® Instrument for High-Throughput Antibody Screeni... 6/8/2022
- Carterra and PerkinElmer Sign Distribution Agreement For Asia-Pacific and Oceania Region 12/15/2021
- Carterra® Announces the Appointment of Joseph D. Keegan, PhD as Executive Chairman of th... 12/3/2020
- Carterra® Announces Successful Immunity Monitoring of COVID-19 Patients 8/18/2020
- Carterra® Inc. Provides Antibody Screening and Characterization for the Coronavirus Immunother... 4/1/2020
- Carterra® Closes Financing Round for Continued Growth of the LSA™ Platform 1/15/2020